Diversified Healthcare Trust
NASDAQ:DHC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Diversified Healthcare Trust
NASDAQ:DHC
|
US |
|
H
|
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
|
CN |
|
Scentre Group
ASX:SCG
|
AU |
|
N
|
Northking Information Technology Co Ltd
SZSE:002987
|
CN |
|
Aedifica NV
F:AOO
|
BE |
|
CrowdStrike Holdings Inc
BMV:CRWD
|
US |
|
Bank KB Bukopin Tbk PT
IDX:BBKP
|
ID |
|
UEX Ltd
TSE:9888
|
JP |
|
Nice Ltd
NASDAQ:NICE
|
IL |
|
O
|
Optima Bank SA
ATHEX:OPTIMA
|
GR |
|
S
|
Shanghai Huitong Energy Co Ltd
SSE:600605
|
CN |
|
O
|
Octodec Investments Ltd
JSE:OCT
|
ZA |
|
D
|
Delta Air Lines Inc
LSE:0QZ4
|
US |
|
Shree Pushkar Chemicals & Fertilisers Ltd
NSE:SHREEPUSHK
|
IN |
|
K
|
Ks Bancorp Inc
OTC:KSBI
|
US |
|
T
|
Tianjin Yiyi Hygiene Products Co Ltd
SZSE:001206
|
CN |
|
A
|
Advanced Oxygen Technologies Inc
OTC:AOXY
|
US |
|
C
|
China Medical & HealthCare Group Ltd
HKEX:383
|
HK |
|
ANZ Group Holdings Ltd
OTC:ANZGY
|
AU |
|
Redstone Resources Ltd
ASX:RDS
|
AU |
|
PRT Company Ltd
ASX:PRT
|
AU |
Diversified Healthcare Trust
Diversified Healthcare Trust is a real estate investment trust, which engages in the ownership of senior living communities, medical office buildings, and wellness centers. The company is headquartered in Newton, Massachusetts and currently employs 600 full-time employees. The firm owns medical office and life science properties, senior living communities, and other healthcare related properties throughout the United States. The firm's segments include Office Portfolio and SHOP. Its Office Portfolio segment consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties leased to biotech laboratories and other similar tenants. Its SHOP segment consists of managed senior living communities that provide short-term and long-term residential living and, in some instances, care and other services for residents where it pays fees to the operator to manage the communities for its account. Its portfolio consists of constructed commercial properties to operate as medical office space for physicians and other healthcare personnel, medical related fields, including clinics and life science or laboratory.
Diversified Healthcare Trust is a real estate investment trust, which engages in the ownership of senior living communities, medical office buildings, and wellness centers. The company is headquartered in Newton, Massachusetts and currently employs 600 full-time employees. The firm owns medical office and life science properties, senior living communities, and other healthcare related properties throughout the United States. The firm's segments include Office Portfolio and SHOP. Its Office Portfolio segment consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties leased to biotech laboratories and other similar tenants. Its SHOP segment consists of managed senior living communities that provide short-term and long-term residential living and, in some instances, care and other services for residents where it pays fees to the operator to manage the communities for its account. Its portfolio consists of constructed commercial properties to operate as medical office space for physicians and other healthcare personnel, medical related fields, including clinics and life science or laboratory.
Record Shareholder Return: DHC was the best-performing REIT in the U.S. for 2025, achieving a total shareholder return of nearly 113%.
Strong NOI Growth: Full year consolidated NOI increased 31.3%, with SHOP NOI up 27.6% YoY to $38.3 million in Q4.
Leverage Reduction: Net debt to adjusted EBITDA fell from 11.2x to 8.1x, with no debt maturities until 2028 after major asset sales and refinancing.
SHOP Portfolio Performance: SHOP same-property occupancy rose 90 bps YoY to 82.4%, with average monthly rates up 5.8% and NOI margin up 230 bps.
Asset Sales & Capital Recycling: 69 properties were sold in 2025 for $605 million, funding debt repayment; future dispositions expected to be opportunistic rather than programmatic.
2026 Guidance: Management expects continued NOI and margin growth, with normalized FFO guidance of $0.52–$0.58 per share.
CapEx Discipline: Capital expenditures are expected to fall over 18% in 2026, with guidance of $100–$115 million.
